Anna J. Duffield‐Lillico

2.2k total citations
15 papers, 1.6k citations indexed

About

Anna J. Duffield‐Lillico is a scholar working on Nutrition and Dietetics, Pharmacology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Anna J. Duffield‐Lillico has authored 15 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nutrition and Dietetics, 5 papers in Pharmacology and 3 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Anna J. Duffield‐Lillico's work include Selenium in Biological Systems (9 papers), Trace Elements in Health (5 papers) and Inflammatory mediators and NSAID effects (5 papers). Anna J. Duffield‐Lillico is often cited by papers focused on Selenium in Biological Systems (9 papers), Trace Elements in Health (5 papers) and Inflammatory mediators and NSAID effects (5 papers). Anna J. Duffield‐Lillico collaborates with scholars based in United States. Anna J. Duffield‐Lillico's co-authors include James R. Marshall, Mary E. Reid, Elizabeth H. Slate, Larry Clark, Bruce W. Turnbull, Gerald F. Combs, Lori Fischbach, Elizabeth T. Jacobs, Marvin Reid and B. W. Turnbull and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Anna J. Duffield‐Lillico

15 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna J. Duffield‐Lillico United States 14 974 441 302 198 193 15 1.6k
Catherine Méplan United Kingdom 27 1.4k 1.4× 601 1.4× 728 2.4× 181 0.9× 110 0.6× 36 2.3k
Giovanna Bermano United Kingdom 25 667 0.7× 244 0.6× 462 1.5× 78 0.4× 76 0.4× 60 1.5k
A. Forbes Howie United Kingdom 24 526 0.5× 159 0.4× 1.0k 3.5× 67 0.3× 74 0.4× 60 1.9k
PR Taylor United States 14 695 0.7× 192 0.4× 345 1.1× 641 3.2× 31 0.2× 17 1.4k
Yuanyuan Sun China 14 553 0.6× 131 0.3× 428 1.4× 677 3.4× 36 0.2× 26 1.8k
J MORROW United States 11 411 0.4× 102 0.2× 431 1.4× 834 4.2× 212 1.1× 12 1.9k
Carmen Tormos Spain 18 357 0.4× 111 0.3× 372 1.2× 377 1.9× 51 0.3× 21 1.6k
Maree Brinkman Australia 20 468 0.5× 216 0.5× 217 0.7× 38 0.2× 43 0.2× 38 1.4k
H Bartsch France 18 217 0.2× 141 0.3× 568 1.9× 92 0.5× 68 0.4× 31 1.4k
Michael S. Morton United Kingdom 23 517 0.5× 91 0.2× 398 1.3× 259 1.3× 54 0.3× 45 2.5k

Countries citing papers authored by Anna J. Duffield‐Lillico

Since Specialization
Citations

This map shows the geographic impact of Anna J. Duffield‐Lillico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna J. Duffield‐Lillico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna J. Duffield‐Lillico more than expected).

Fields of papers citing papers by Anna J. Duffield‐Lillico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna J. Duffield‐Lillico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna J. Duffield‐Lillico. The network helps show where Anna J. Duffield‐Lillico may publish in the future.

Co-authorship network of co-authors of Anna J. Duffield‐Lillico

This figure shows the co-authorship network connecting the top 25 collaborators of Anna J. Duffield‐Lillico. A scholar is included among the top collaborators of Anna J. Duffield‐Lillico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna J. Duffield‐Lillico. Anna J. Duffield‐Lillico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mohebati, Arash, Ginger L. Milne, Xi Kathy Zhou, et al.. (2013). Effect of Zileuton and Celecoxib on Urinary LTE4 and PGE-M Levels in Smokers. Cancer Prevention Research. 6(7). 646–655. 21 indexed citations
2.
Duffield‐Lillico, Anna J., Jay O. Boyle, Xi Kathy Zhou, et al.. (2009). Levels of Prostaglandin E Metabolite and Leukotriene E4 Are Increased in the Urine of Smokers: Evidence that Celecoxib Shunts Arachidonic Acid into the 5-Lipoxygenase Pathway. Cancer Prevention Research. 2(4). 322–329. 91 indexed citations
3.
Kekatpure, Vikram D., Jay O. Boyle, Xi Kathy Zhou, et al.. (2009). Elevated Levels of Urinary Prostaglandin E Metabolite Indicate a Poor Prognosis in Ever Smoker Head and Neck Squamous Cell Carcinoma Patients. Cancer Prevention Research. 2(11). 957–965. 21 indexed citations
4.
Reid, Mary E., Anna J. Duffield‐Lillico, Elizabeth H. Slate, et al.. (2008). The Nutritional Prevention of Cancer: 400 Mcg Per Day Selenium Treatment. Nutrition and Cancer. 60(2). 155–163. 102 indexed citations
5.
Altorki, Nasser K., Jeffrey L. Port, Fan Zhang, et al.. (2005). Chemotherapy Induces the Expression of Cyclooxygenase-2 in Non–Small Cell Lung Cancer. Clinical Cancer Research. 11(11). 4191–4197. 52 indexed citations
6.
Reid, Mary E., Anna J. Duffield‐Lillico, Annette Y. Sunga, et al.. (2005). Selenium supplementation and colorectal adenomas: An analysis of the nutritional prevention of cancer trial. International Journal of Cancer. 118(7). 1777–1781. 61 indexed citations
7.
Gross, Neil D., Jay O. Boyle, Jason D. Morrow, et al.. (2005). Levels of Prostaglandin E Metabolite, the Major Urinary Metabolite of Prostaglandin E2, Are Increased in Smokers. Clinical Cancer Research. 11(16). 6087–6093. 55 indexed citations
8.
Duffield‐Lillico, Anna J., Imad Shureiqi, & S. M. Lippman. (2004). Can Selenium Prevent Colorectal Cancer? A Signpost From Epidemiology. JNCI Journal of the National Cancer Institute. 96(22). 1645–1647. 15 indexed citations
9.
Duffield‐Lillico, Anna J.. (2003). Selenium Supplementation and Secondary Prevention of Nonmelanoma Skin Cancer in a Randomized Trial. JNCI Journal of the National Cancer Institute. 95(19). 1477–1481. 197 indexed citations
10.
Duffield‐Lillico, Anna J., B.L. Dalkin, Marvin Reid, et al.. (2003). Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. British Journal of Urology. 91(7). 608–612. 360 indexed citations
11.
Duffield‐Lillico, Anna J., Mary E. Reid, Bruce W. Turnbull, et al.. (2002). Baseline Characteristics and the Effect of Selenium Supplementation on Cancer Incidence in a Randomized Clinical Trial. Cancer Epidemiology and Prevention Biomarkers. 11(7). 630–639. 13 indexed citations
12.
Reid, Mary E., Anna J. Duffield‐Lillico, Linda L. Garland, et al.. (2002). Selenium Supplementation and Lung Cancer Incidence. Cancer Epidemiology and Prevention Biomarkers. 11(11). 1285–1291. 6 indexed citations
13.
Nelson, Mark A., Mary E. Reid, Anna J. Duffield‐Lillico, & James R. Marshall. (2002). Prostate cancer and selenium. Urologic Clinics of North America. 29(1). 67–70. 28 indexed citations
14.
Reid, Mary E., Anna J. Duffield‐Lillico, Linda L. Garland, et al.. (2002). Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.. PubMed. 11(11). 1285–91. 156 indexed citations
15.
Duffield‐Lillico, Anna J., Mary E. Reid, Bruce W. Turnbull, et al.. (2002). Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.. PubMed. 11(7). 630–9. 427 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Méplan Breakdown of academic impact, for papers by Giovanna Bermano Breakdown of academic impact, for papers by A. Forbes Howie Breakdown of academic impact, for papers by PR Taylor Breakdown of academic impact, for papers by Yuanyuan Sun Breakdown of academic impact, for papers by J MORROW Breakdown of academic impact, for papers by Carmen Tormos Breakdown of academic impact, for papers by Maree Brinkman Breakdown of academic impact, for papers by H Bartsch Breakdown of academic impact, for papers by Michael S. Morton
Rankless by CCL
2026